The European journal of neuroscience

Controlling Brain Immune Cells by GLP-1 Pathways: A New Approach to Brain Inflammation

Updated

Abstract

GLP-1 receptor agonists (GLP-1 RAs) may shift microglia to a protective anti-inflammatory state.

  • Microglia are immune cells in the central nervous system that can adopt pro-inflammatory (M1) or anti-inflammatory (M2) states.
  • The M1 state is associated with neurotoxicity, while the M2 state contributes to tissue repair.
  • Activation of microglia plays a role in neuroinflammation and pain sensitivity in neurodegenerative disorders like Parkinson's and Alzheimer's diseases.
  • GLP-1 RAs can bind to receptors on microglia, promoting a shift towards the anti-inflammatory M2 phenotype.
  • Preclinical models indicate that GLP-1 RAs may reduce pain hypersensitivity, enhance cognitive function, and diminish inflammatory responses.
  • These findings suggest that GLP-1 RAs could be a viable treatment for chronic pain and neurodegenerative diseases through their effects on microglial activity.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free